skip to the main content
Contact Us
Go Search
Go Search Menu

Adalimumab

Measuring Adalimumab drug concentrations in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Adalimumab allows for reliable measurement of Adalimumab drug levels using just a small amount of human serum, plasma, or whole blood, delivering results in 10 minutes. This allows clinicians to confirm the drug levels of Adalimumab immediately before the next administration.

  • CE

Available Instruments

AFIAS-1 AFIAS-3 AFIAS-6 AFIAS-10

About Using Reagent

  • Sample Types

    Whole blood, Serum, Plasma

  • Reaction Time

    10 mins

  • Detection Range

    0.2-50 μg/mL

  • Intended Use

    Quantitative determination of free adalimumab in human whole blood/serum/plasma

In Your Medical Field

AFIAS Adalimumab measures Adalimumab drug levels in patients' blood, using whole blood, serum, or plasma samples. This allows clinicians to obtain TDM results within just 10 minutes. It provides valuable insights into patients’ response to the treatment of Adalimumab.